Position
Fidelity in Fate Therapeutics Inc
Back to the book · All holders of FATE
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark $71.4K$1.20 → $2.70
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 12.8K | $12.5K | — | — | — | 0.0% |
| Q1 2026 | 47.6K | $57.1K | $1.20 | $2.77K | $41.8K | 0.0% |
| Q2 2026 | 49.1K | $132.5K | $2.70 | $71.4K | $4.01K | 0.0% |